Students in leadership positions learn about brain tumors and gain real world experience in running a non-profit business while raising funds for brain tumor research. Beneficiaries of the money we raise are Barrow Neurological Institute, National Brain Tumor Society, Phoenix Childrens Hospital, Steele Childrens Research Center in Tucson, and Translational Genomics Research Institute (TGen). With your help we can make a difference. The intent of our website is to further our objectives of disseminating information about this disease process, stimulating more widespread involvement within our community through donating, volunteering and participating in one or more of our events, and publicizing and promoting this exceptional student-run organization.

"Be the change you wish to see in the world..." Gandhi

Thanks for visiting. Your support is greatly appreciated.

SSBTR on the News


Philanthropic "Quotes"

  • “No one is useless in this world who lightens the burdens of another.”

  • “There is no cause half so sacred as the cause of a people. There is no idea so uplifting as the idea of the service of humanity.”

  • “When it comes to helping out, I don’t believe in doing it for the media attention. My goal is to support the organizations that need help.”



Brain Tumor News

  • The biotech firm Tocagen Inc. plans an Initial Public Offering to finance ongoing clinical trials of a technique that uses a weaponized virus to help the body’s immune system battle a common and deadly type of brain cancer.

  • The landscape for the treatment of brain cancer is improving, with researchers and patient advocates hoping the surge in clinical studies will pave the way for new approaches and drug combinations to treat these tumors.

  • When you hear the word Salmonella, you probably think about food poisoning rather than fighting brain cancer. However, one strain of the notorious bacterium may be able to do both.

  • Five types of pediatric brain cancer were safely and effectively treated in mice by an antibody that causes immune cells to engulf and eat tumors without hurting healthy brain cells, according to a new study by researchers at the Stanford University School of Medicine.

  • Cedars-Sinai investigators have identified a stem cell-regulating gene that affects tumor growth in patients with brain cancer and can strongly influence survival rates of patients. The findings could move physicians closer to their goal of better predicting the prognosis of patients with brain tumors and developing more personalized treatments for them.

blank line

SSBTR in the News

  • A new class of therapies called SMAC mimetics could work in conjunction with immune checkpoint inhibitors to treat brain cancer patients, according to a study. SMAC mimetics block the activity of proteins that prevent cell death while sensitizing tumors to allow immune cells to attack them.

  • Researchers at the Yale School of Medicine’s Department of Therapeutic Radiology have identified a genetic defect in brain tumor cells that makes them sensitive to a class of drugs known as PARP inhibitors.

© Copyright 2017